Euro devaluation colours Cosmo profits in first half
This article was originally published in Scrip
Executive Summary
A foreign exchange loss on the put option issued as part of its recent acquisition of BioXell dragged Italian firm Cosmo Pharmaceuticals' net profit down by 75% to €500,000 in the first half of 2010.